1. Inflammasomes in the pathobiology of degenerative retinopathies
   Eoin Silke et al, 2023, Inflammasome Biology CrossRef
2. Knockdown of ChREBP ameliorates retinal microvascular endothelial cell injury and angiogenic responses in diabetic retinopathy
   Yao Sui et al, 2024, Biochemical and Biophysical Research Communications CrossRef
3. The Impact of LncRNA Nuclear-Enriched Abundant Transcript 1-Mediated Regulation of ASK1 Expression via miR-20a on High Glucose-Induced Retinal Vascular Endothelial Cell Injury
   Ling Zhao et al, 2024, Journal of Biomedical Nanotechnology CrossRef
4. Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis
   Zhiheng Zhu et al, 2021, International Immunopharmacology CrossRef
5. Trimethylamine-N-Oxide Promotes High-Glucose-Induced Dysfunction and NLRP3 Inflammasome Activation in Retinal Microvascular Endothelial Cells
   Lidan Xue et al, 2023, Journal of Ophthalmology CrossRef
6. lncRNA HOTAIR promotes ROS generation and NLRP3 inflammasome activation by inhibiting Nrf2 in diabetic retinopathy
   Hui You et al, 2023, Medicine CrossRef
7. Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy
   Caterina Claudia Lepre et al, 2023, International Journal of Molecular Sciences CrossRef
8. E3 ubiquitin ligase mind bomb 1 overexpression reduces apoptosis and inflammation of cardiac microvascular endothelial cells in coronary microvascular dysfunction
   Xiao-fei Qin et al, 2022, Cellular Signalling CrossRef
9. The mechanism by which crocetin regulates the lncRNA NEAT1/miR-125b-5p/SOX7 molecular axis to inhibit high glucose-induced diabetic retinopathy
   Qianbo Chen et al, 2022, Experimental Eye Research CrossRef
10. Atypical p38 Signaling, Activation, and Implications for Disease
    Jeremy C. Burton et al, 2021, International Journal of Molecular Sciences CrossRef
11. Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases
    Meini Chen et al, 2022, Journal of Neuroinflammation CrossRef
12. Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway
    Ke-Xin Sun et al, 2023, World Journal of Diabetes CrossRef
13. Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications
    Xiaolin Lu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
14. Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies
    Yuxuan Yang et al, 2023, Biochemical Pharmacology CrossRef
15. NLRP3 and pyroptosis blockers for treating inflammatory diseases
    Rebecca C. Coll et al, 2022, Trends in Pharmacological Sciences CrossRef
16. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
    Chi Teng Vong et al, 2021, Drug Discovery Today CrossRef
17. Crosstalk between inflammasomes, inflammation, and Nrf2: Implications for gestational diabetes mellitus pathogenesis and therapeutics
    Vijaya Gayatri et al, 2024, European Journal of Pharmacology CrossRef
18. Redoxisome and diabetic retinopathy: Pathophysiology and therapeutic interventions
    Isha Sharma et al, 2022, Pharmacological Research CrossRef